CAMERON FREEMAN: Open Payments
NPI 1174860878 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 44 payments from 9 companies in 2025. Trend: 2023 $618 · 2024 $725 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $248 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $126 |
| E.R. Squibb & Sons, L.L.C. | 4 | $97 |
| Corcept Therapeutics | 4 | $69 |
| Lundbeck LLC | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Exact Sciences Corporation | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, COBENFY, Korlym, REXULTI, QULIPTA, AUSTEDO XR, The Cologuard Plus Collection Kit.
Industry payments across ID — which companies pay providers there.
